Alkem Laboratories has entered into an asset purchase agreement with AbbVie Inc., USA for acquisition of certain assets related to the active pharmaceutical ingredient, Dronabinol which include domain names and trademarks related to ‘Marinol’, New Drug Application registration with USFDA for Marinol, logos, patents designs, know how, technical and manufacturing instructions, inventory manufacturing equipment and such items. The company shall own the NDA and associated assets and will use these to commercially exploit both Branded and Generic sales in US.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |